相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Natural History of Cerebral Dural Arteriovenous Fistulae
Bradley A. Gross et al.
NEUROSURGERY (2012)
A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors
Matthew H. Kulke et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
LOCAL CHRONIC HYPOPERFUSION SECONDARY TO SINUS HIGH PRESSURE SEEMS TO BE MAINLY RESPONSIBLE FOR THE FORMATION OF INTRACRANIAL DURAL ARTERIOVENOUS FISTULA
Liang Chen et al.
NEUROSURGERY (2009)
2-methoxyestradiol suppresses osteolytic breast cancer tumor progression in vivo
Muzaffer Cicek et al.
CANCER RESEARCH (2007)
Inhibitor of DNA binding 1 activates vascular endothelial growth factor through enhancing the stability and activity of hypoxia-inducible factor-1α
Hyun-Jun Kim et al.
MOLECULAR CANCER RESEARCH (2007)
Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer
Jehana James et al.
INVESTIGATIONAL NEW DRUGS (2007)
Hypoxia-inducible factor-1 (HIF-1)
Qingdong Ke et al.
MOLECULAR PHARMACOLOGY (2006)
Expression of hypoxia-inducible factor-1 and vascular endothelial growth factor in response to venous hypertension
Yiqian Zhu et al.
NEUROSURGERY (2006)
Role of matrix metalloproteinases in delayed cortical responses after stroke
BQ Zhao et al.
NATURE MEDICINE (2006)
Distinct tumor stage-specific inhibitory effects of 2-methoxyestradiol in a breast cancer mouse model associated with Id-1 expression
JI Huh et al.
CANCER RESEARCH (2006)
Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors
WL Dahut et al.
CANCER BIOLOGY & THERAPY (2006)
A phase II multicenter, randomized, double-blind, safety trial assessing the pharmacokinetics, pharmacodynamics, and efficacy of oral 2-methoxyestradiol capsules in hormone-refractory prostate cancer
C Sweeney et al.
CLINICAL CANCER RESEARCH (2005)
Id proteins in development, cell cycle and cancer
MB Ruzinova et al.
TRENDS IN CELL BIOLOGY (2003)
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF
NJ Mabjeesh et al.
CANCER CELL (2003)
2-methoxyestradiol and analogs as novel antiproliferative agents: Analysis of three-dimensional quantitative structure-activity relationships for DNA synthesis inhibition and estrogen receptor binding
RA Hughes et al.
MOLECULAR PHARMACOLOGY (2002)
分享论文
